Marshall Wace North America’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,579
Closed -$660K 1686
2020
Q4
$660K Sell
5,579
-21,722
-80% -$2.53M ﹤0.01% 1028
2020
Q3
$2.88M Sell
27,301
-5,617
-17% -$594K 0.02% 493
2020
Q2
$3.51M Buy
+32,918
New +$3.06M 0.02% 438
2020
Q1
Sell
-12,633
Closed -$1.12M 1483
2019
Q4
$1.12M Buy
+12,633
New +$1.09M 0.01% 702
2019
Q1
Sell
-911
Closed -$57K 1789
2018
Q4
$57K Buy
+911
New +$58.7K ﹤0.01% 1219
2017
Q4
Sell
-12,273
Closed -$540K 1531
2017
Q3
$540K Buy
+12,273
New +$477K ﹤0.01% 1055

Other funds holding NOVT

Marshall Wace North America's NOVT Position: Q1 2021 in Review

Marshall Wace North America sold out of Novanta (NOVT) in Q1 2021, closing a stake of 5,579 shares — an estimated $660K sold.

Marshall Wace North America first reported a position in NOVT in Q3 2017 and held it in 6 quarters. The position peaked at $3.51M in Q2 2020. 199 funds tracked by Wall St. Rank hold NOVT as of Q1 2021.

  • Marshall Wace North America reported no remaining Novanta position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 5,579 Novanta shares in Q1 2021, an estimated $660K.
  • Marshall Wace North America first reported a position in Novanta in Q3 2017 and held it in 6 quarters.
  • Marshall Wace North America's Novanta position peaked at $3.51M in Q2 2020.
  • 199 funds tracked by Wall St. Rank held Novanta as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.